US Patent Issued to Novozymes on Dec. 9 for "Lipase variants and microcapsule compositions comprising such lipase variants" (Danish Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,387, issued on Dec. 9, was assigned to Novozymes A/S (Bagsvaerd, Denmark).

"Lipase variants and microcapsule compositions comprising such lipase variants" was invented by Miguel Duarte Guilherme Pereira Toscano (Frederiksberg, Denmark), Thomas Agersten Poulsen (Ballerup, Denmark), Carsten Horslev Hansen (Vaerloese, Denmark), Lone Baunsgaard (Helsingor, Denmark) and Keith Gibson (Bagsvaerd, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to variants of a parent lipase which has lipase activity and comprise one or more substitutions corresponding to G23S, D27N, A401, F51I,L, E56R, D57N, V60E, K, K981, N101D, R118F, ...